Summary
Studies on the effects of age on the pharmacokinetics of alfentanil are inconclusive. A possible factor in explaining the differences between various studies could be the effect of gender. The authors studied the effects of age on the pharmacokinetics of alfentanil in female (n = 21) and male (n = 15) patients undergoing lower abdominal surgery under nitrous oxide alfentanil anaesthesia. There was a significant negative correlation (r = −0.79, p < 0.001) between plasma alfentanil clearance (CL) and age in women (<50y, median CL 24.84 L/h; >50y, median CL 14.52 L/h), but not in men (<50y, median CL 19.44 L/h; >50y, median CL 16.2 L/h). The conclusion is drawn that the effects of age on the pharmacokinetics of alfentanil are gender-dependent.
Similar content being viewed by others
References
Ausems ME, Vuyk J, Hug Jr CC, Stanski DR. Comparison of a computer assisted infusion versus intermittent bolus administration of alfentanil as a supplement to nitrous oxide for lower abdominal surgery. Anesthesiology 68: 851–861, 1988
Bartkowski RR, Goldberg ME, Larijani GE, Boerner TF. Inhibition of alfentanil metabolism by erythromycin. Clinical Pharmacology and therapeutics 46: 99–102, 1989
Bovill JG, Sebel PS, Blackburn CL, Heykants J. The pharmacokinetics of alfentanil (R 39209): a new opioid analgesic. Anesthesiology 57: 439–443, 1982
Gibaldi M, Perrier D. Pharmacokinetics, 2nd ed.; pp. 84–109, Marcel Dekker Inc., New York, 1982
Greenblatt DJ, Abemethy DR, Locniskar A, Harmalz JS, Limjuco RA, et al. Effects of age, gender, and obesity of midazolam kinetics. Anesthesiology 61: 27–35, 1984
Greenblatt DJ, Allen MD, Harmatz JS, Shader RI. Diazepam disposition determinants. Clinical Pharmacology and Therapeutics 27: 301–313, 1980
Helmers JH, van Peer H, Woestenborghs R, Noorduin H, Heykants J. Alfentanil kinetics in the elderly. Clinical Pharmacology and Therapeutics 36: 239–243, 1984
Lemmens HIM, Bovill JG, Hennis PJ, Burm AGL. Age has no effect on the pharmacodynamics on alfentanil. Anesthesia and Analgesia 67: 956–960, 1988
Maitre PO, Vo>zeh S, Heykants J, Thomson DA, Stanski DR. Population pharmacokinetics of alfentanil: the average doseplasma concentration relationship and interindividual variability in patients. Anesthesiology 66: 3–12, 1987
Mather LE. Clinical pharmacokinetics of fentanyl and its newer derivates. Clinical Pharmacokinetics 8: 422–446, 1983
Schmucker DL. Alterations in drug disposition. In Stephen & Assaf (Eds) Geriatric anesthesia: principles and practice, p 164, Butterworths, Boston, 1986
Scott JC, Stanski DR. Decreased fentanyl and alfentanil dose requirements with age: a simultaneous pharmacokinetic and pharmacodynamic evaluation. Journal of Pharmacology and Experimental Therapeutics 240: 159–166, 1987
Wagner JG. A safe method for rapidly achieving plasma concentration plateaus. Clinical Pharmacology and Therapeutics 16: 691–700, 1974
Wilkinson GR, Shand DG. A physiological approach to hepatic drug clearance. Clinical Pharmacology and Therapeutics 18: 377–390, 1975
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lemmens, H.J.M., Burm, A.G.L., Hennis, P.J. et al. Influence of Age on the Pharmacokinetics of Alfentanil. Clin Pharmacokinet 19, 416–422 (1990). https://doi.org/10.2165/00003088-199019050-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-199019050-00005